P. gingivalis-host interactions direct antibiotic adjuvants for periodontitis antimicrobial therapy

Abstract

Porphyromonas gingivalis (P. gingivalis) invades host cells to evade antibiotics, driving the recurrence of periodontitis. However, current clinical treatment strategies remain ineffective in addressing this intracellular invasion by the bacteria. Here, we report a host-directed strategy that blocks bacterial invasion by targeting key host factors, including collagen I (using FT011), lipid rafts (using simvastatin), integrin β1 (using ATN-161), and FAK signaling (using YH-306). Inhibiting these targets significantly reduced P. gingivalis infection in human oral keratinocytes and periodontal ligament stem cells. Crucially, simvastatin restored the osteogenic ability of P. gingivalis-infected PDLSCs. These drugs subsequently functioned as effective antibiotic adjuvants. The combination of simvastatin or YH-306 with metronidazole, a standard-of-care antibiotic for periodontitis, exhibited potent synergistic effects, significantly eradicating intracellular bacteria at reduced antibiotic dosages. In a rat periodontitis model, simvastatin-metronidazole therapy yielded superior outcomes, significantly mitigating bacterial load, inflammation, and alveolar bone loss. The repurposing of clinically available drugs, such as simvastatin, as antibiotic adjuvants represents a promising, readily translatable therapeutic approach for periodontitis.

References

[1] Trindade D, et al. . Prevalence of periodontitis in dentate people between 2011 and 2020: A systematic review and meta-analysis of epidemiological studies. J. Clin. Periodontol., 2023, 50: 604-626

[2] Peres MA, et al. . Oral diseases: a global public health challenge. Lancet, 2019, 394: 249-260

[3] Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat. Rev. Microbiol., 2012, 10: 717-725

[4] Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the ‘red complex’, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000, 2005, 38: 72-122

[5] Guo Y, Nguyen K-A, Potempa J. Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon’s knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000, 2010, 54: 15-44

[6] Mysak J, et al. . Porphyromonas gingivalis: Major Periodontopathic Pathogen Overview. J. Immunol. Res., 2014, 2014 476068

[7] Jia L, et al. . Pathogenesis of important virulence factors of porphyromonas gingivalis via toll-like receptors. Front. Cell Infect. Microbiol., 2019, 9: 262

[8] Castro SA, et al. . Porphyromonas gingivalis gingipains cause defective macrophage migration towards apoptotic cells and inhibit phagocytosis of primary apoptotic neutrophils. Cell Death Dis., 2017, 8 e2644

[9] Pan C, et al. . Porphyromonas gingivalis can invade periodontal ligament stem cells. BMC Microbiol., 2017, 17: 38

[10] Yilmaz O, Verbeke P, Lamont RJ, Ojcius DM. Intercellular spreading of Porphyromonas gingivalis infection in primary gingival epithelial cells. Infect. Immun., 2006, 74: 703-710

[11] Wang C, Cheng T, Li X, Jin L. Metronidazole-treated Porphyromonas gingivalis persisters invade human gingival epithelial cells and perturb innate responses. Antimicrob. Agents Chemother., 2020, 64: e02529-19

[12] Li L, Michel R, Cohen J, Decarlo A, Kozarov E. Intracellular survival and vascular cell-to-cell transmission of porphyromonas gingivalis. BMC Microbiol., 2008, 8: 26

[13] Eick S, Pfister W. Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study. J. Periodontol., 2004, 75: 1327-1334

[14] Irshad M, van der Reijden WA, Crielaard W, Laine ML. In vitro invasion and survival of Porphyromonas gingivalis in gingival fibroblasts; role of the capsule. Arch. Immunol. Ther. Exp., 2012, 60: 469-476

[15] Rams TE, Sautter JD, van Winkelhoff AJ. Emergence of antibiotic-resistant porphyromonas gingivalis in United States periodontitis patients. Antibiotics, 2023, 12: 1584

[16] Johnson JD, et al. . Persistence of extracrevicular bacterial reservoirs after treatment of aggressive periodontitis. J. Periodontol., 2008, 79: 2305-2312

[17] Chang Y-T, Lai C-C, Lin D-J. Collagen scaffolds laden with human periodontal ligament fibroblasts promote periodontal regeneration in SD rat model. Polymers, 2023, 15: 2649

[18] Zhou J, Windsor LJ. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases. J. Periodontal Res., 2006, 41: 47-54

[19] Zhou J, Windsor LJ. Heterogeneity in the collagen-degrading ability of Porphyromonas gingivalis-stimulated human gingival fibroblasts. J. Periodontal Res., 2007, 42: 77-84

[20] Hintermann E, Haake SK, Christen U, Sharabi A, Quaranta V. Discrete proteolysis of focal contact and adherens junction components in Porphyromonas gingivalis-infected oral keratinocytes: a strategy for cell adhesion and migration disabling. Infect. Immun., 2002, 70: 5846-5856

[21] Xu H, et al. . Bacterial-host adhesion dominated by collagen subtypes remodelled by osmotic pressure. NPJ Biofilms Microbiomes, 2024, 10 124

[22] Feng Y, et al. . Geometric constraint-triggered collagen expression mediates bacterial-host adhesion. Nat. Commun., 2023, 14 8165

[23] Saito A, et al. . Porphyromonas gingivalis entry into gingival epithelial cells modulated by Fusobacterium nucleatum is dependent on lipid rafts. Micro. Pathog., 2012, 53: 234-242

[24] Takeuchi H, Furuta N, Amano A. Cell entry and exit by periodontal pathogen via recycling pathway. Commun. Integr. Biol., 2011, 4: 587-589

[25] Yilmaz O, Watanabe K, Lamont RJ. Involvement of integrins in fimbriae-mediated binding and invasion by Porphyromonas gingivalis. Cell Microbiol, 2002, 4: 305-314

[26] Takeshita A, et al. . Porphyromonas gingivalis Fimbriae Use β2 Integrin (CD11/CD18) on mouse peritoneal macrophages as a cellular receptor, and the CD18 β chain plays a functional role in fimbrial signaling. Infect. Immun., 1998, 66: 4056-4060

[27] Nakagawa I, et al. . Functional differences among FimA variants of porphyromonas gingivalis and their effects on adhesion to and invasion of human epithelial cells. Infect. Immun., 2002, 70: 277-285

[28] Yilmaz Ö, Young PA, Lamont RJ, Kenny GE. Gingival epithelial cell signalling and cytoskeletal responses to Porphyromonas gingivalis invasion. Microbiology, 2003, 149: 2417-2426

[29] Liu X, Wu Y, Mao C, Shen J, Zhu K. Host-acting antibacterial compounds combat cytosolic bacteria. Trends Microbiol., 2022, 30: 761-777

[30] Feng Y, et al. . Harnessing RGDS peptides to regulate bacterial-host interfaces for targeted antimicrobial therapy. J. Control Release, 2025, 384 113922

[31] Kaku M, Yamauchi M. Mechano-regulation of Collagen biosynthesis in periodontal ligament. J. Prosthodont Res., 2014, 58: 193-207

[32] Zhang Y, et al. . A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction. Int. J. Cardiol., 2013, 168: 1174-1185

[33] Stoeltzing O, et al. . Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int. J. Cancer, 2003, 104: 496-503

[34] Dai F, et al. . A novel synthetic small molecule YH-306 suppresses colorectal tumour growth and metastasis via FAK pathway. J. Cell Mol. Med., 2015, 19: 383-395

[35] Karthikeyan S, et al. . Statin drugs and lipid modulation: Mechanistic basis considering lipid rafts, kinase signaling, myopathy, and cancer. Pharm. Res., 2025, 220: 107912

[36] Adam O, et al. . Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J. Am. Coll. Cardiol., 2010, 55: 469-480

[37] Kidera Y, et al. . Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway. J. Exp. Clin. Cancer Res., 2010, 29: 127

[38] Jung JY, et al. . Simvastatin inhibits the expression of inflammatory cytokines and cell adhesion molecules induced by LPS in human dental pulp cells. Int. Endod. J., 2017, 50: 377-386

[39] Eccles KA, et al. . Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow. Atherosclerosis, 2008, 200: 69-79

[40] Jin H, et al. . Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery. Theranostics, 2019, 9: 265-278

[41] de Jongh CA, de Vries TJ, Bikker FJ, Gibbs S, Krom BP. Mechanisms of Porphyromonas gingivalis to translocate over the oral mucosa and other tissue barriers. J. Oral. Microbiol., 2023, 15: 2205291

[42] Farrugia C, et al. . Mechanisms of vascular damage by systemic dissemination of the oral pathogen Porphyromonas gingivalis. FEBS J., 2021, 288: 1479-1495

[43] López-Colomé AM, Lee-Rivera I, Benavides-Hidalgo R, López E. Paxillin: a crossroad in pathological cell migration. J. Hematol. Oncol., 2017, 10: 50

[44] Alday-Parejo B, et al. . MAGI1 localizes to mature focal adhesion and modulates endothelial cell adhesion, migration and angiogenesis. Cell Adhes. Migr., 2021, 15: 126-139

[45] Carrasco-Ceballos JM, et al. . Involvement of the PRL-PAK1 pathway in cancer cell migration. Cancer Diagn. Progn., 2023, 3: 17-25

[46] Lamont RJ, Miller DP, Bagaitkar J. Illuminating the oral microbiome: cellular microbiology. FEMS Microbiol. Rev., 2023, 47: fuad045

[47] Lee B-H, Ruoslahti E. alpha5beta1 integrin stimulates Bcl-2 expression and cell survival through Akt, focal adhesion kinase, and Ca2+/calmodulin-dependent protein kinase IV. J. Cell Biochem., 2005, 95: 1214-1223

[48] Scibelli A, et al. . Engagement of integrins as a cellular route of invasion by bacterial pathogens. Vet. J., 2007, 173: 482-491

[49] Izawa Y, et al. . β1-integrin–matrix interactions modulate cerebral microvessel endothelial cell tight junction expression and permeability. J. Cereb. Blood Flow. Metab., 2018, 38: 641-658

[50] Kozlova NI, Morozevich GE, Gevorkian NM, Berman AE. Implication of integrins α3β1 and α5β1 in invasion and anoikis of SK-Mel-147 human melanoma cells: non-canonical functions of protein kinase Akt. Aging, 2020, 12: 24345-24356

[51] Miteva M, et al. . A review of stem cell attributes derived from the oral cavity. Int. Dent. J., 2024, 74: 1129-1141

[52] Hujiahemaiti M, et al. . Effects of quercetin on human oral keratinocytes during re-epithelialization: an in vitro study. Arch. Oral. Biol., 2018, 95: 187-194

[53] Nakagawa I, Amano A, Inaba H, Kawai S, Hamada S. Inhibitory effects of Porphyromonas gingivalis fimbriae on interactions between extracellular matrix proteins and cellular integrins. Microbes Infect., 2005, 7: 157-163

[54] Wright GD. Antibiotic adjuvants: rescuing antibiotics from resistance. Trends Microbiol., 2016, 24: 862-871

[55] Tyers M, Wright GD. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat. Rev. Microbiol., 2019, 17: 141-155

[56] Samuelson J. Why metronidazole is active against both bacteria and parasites. Antimicrob. Agents Chemother., 1999, 43: 1533-1541

[57] Annakkaya N, Çavuşoğlu K, Yalçin E, Özkan B. Investigation of in-vivo and in-silico toxicity induced by environmental drug contamination in a non-target organism. Sci. Rep., 2025, 15 21082

[58] Wang C, Li X, Cheng T, Sun H, Jin L. Eradication of porphyromonas gingivalis persisters through colloidal bismuth subcitrate synergistically combined with metronidazole. Front. Microbiol, 2021, 12: 748121

[59] Hotinger JA, Morris ST, May AE. The case against antibiotics and for anti-virulence therapeutics. Microorganisms, 2021, 9: 2049

[60] Messina BM, et al. . Impact of periodontal host-modulation therapies on oral–gut microbiome axis in periodontitis patients with hematological diseases: a narrative review. LIFE, 2025, 15: 1862

[61] Brannon JR, Hadjifrangiskou M. The arsenal of pathogens and antivirulence therapeutic strategies for disarming them. Drug Des. Dev. Ther., 2016, 10: 1795-1806

[62] Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev., 2008, 32: 234-258

[63] Whitaker EJ, Alshammari A. Bacteriostatic effect of simvastatin on selected oral streptococci in vitro. Contemp. Clin. Dent., 2017, 8: 59-63

[64] Liao JK. Isoprenoids as mediators of the biological effects of statins. J. Clin. Invest., 2002, 110: 285-288

[65] Haeri MR, White K, Qharebeglou M, Ansar MM. Cholesterol suppresses the antimicrobial effect of statins. Iran. J. Basic Med. Sci., 2015, 18: 1253-1256

[66] Zandbergen D, Slot DE, Niederman R, Van der Weijden FA. The concomitant administration of systemic amoxicillin and metronidazole compared to scaling and root planing alone in treating periodontitis: a systematic review. BMC Oral. Health, 2016, 16 27

[67] Yuan X, et al. . Vascularized pulp regeneration via injecting simvastatin functionalized GelMA cryogel microspheres loaded with stem cells from human exfoliated deciduous teeth. Mater. Today Bio, 2022, 13 100209

[68] Shao P-L, et al. . Alpha-5 Integrin mediates Simvastatin-induced osteogenesis of bone marrow mesenchymal stem cells. Int. J. Mol. Sci., 2019, 20: 506

[69] Shadmehr E, Khademi A. Effect of simvastatin on kinetics of osteoprotegrin/receptor activator nuclear kappa B Ligand mRNA expression in periapical lesions. Int. Endod. J., 2013, 46: 1077-1082

[70] Sanz M, et al. . Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline. J. Clin. Periodontol., 2020, 47: 4-60

[71] Lee Y, et al. . The effect of local simvastatin delivery strategies on mandibular bone formation In vivo. Biomaterials, 2008, 29: 1940-1949

[72] Ahmed LM, Hassanein KMA, Mohamed FA, Elfaham TH. Formulation and evaluation of simvastatin cubosomal nanoparticles for assessing its wound healing effect. Sci. Rep., 2023, 13 17941

[73] Wang C-C, et al. . Topical simvastatin promotes healing of staphylococcus aureus-contaminated cutaneous wounds. Int Wound J., 2015, 13: 1150-1157

[74] Prueksaritanont T, Ma B, Yu N. The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6. Br. J. Clin. Pharm., 2003, 56: 120-124

[75] Hernández-Lorca M, et al. . Dietary modulation of CYP3A4 and its impact on statins and antidiabetic drugs: a narrative review. Pharmaceuticals, 2025, 18: 1351

[76] Han Y, et al. . Tissue geometry spatiotemporally drives bacterial infections. Cell, 2025, 188: 3459-3476.e21

[77] Chen WA, Dou Y, Fletcher HM, Boskovic DS. Local and Systemic Effects of Porphyromonas gingivalis Infection. Microorganisms, 2023, 11: 470

[78] Hasegawa Y, Nagano K. Porphyromonas gingivalis FimA and Mfa1 fimbriae: Current insights on localization, function, biogenesis, and genotype. Jpn Dent. Sci. Rev., 2021, 57: 190-200

[79] Yan N, et al. . Penetrating macrophage-based nanoformulation for periodontitis treatment. ACS Nano, 2022, 16: 18253-18265

[80] Morillo JM, et al. . Quantitative real-time polymerase chain reaction based on single copy gene sequence for detection of periodontal pathogens. J. Clin. Periodontol., 2004, 31: 1054-1060

Funding

Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)(L222144)

Peking University Third Hospital (PUTH)(BYSYJC2025057)

RIGHTS & PERMISSIONS

The Author(s)